Patents by Inventor Kunio Matsumoto

Kunio Matsumoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10626345
    Abstract: In a threaded joint for pipes constituted by a pin and a box, each having a contact surface comprising a threaded portion and an unthreaded metal contact portion, the contact surface of the pin has a solid corrosion protective, preferably transparent coating based on a UV-curable resin and the contact surface of the box has a solid lubricating coating having plastic or viscoplastic rheological behavior which is preferably formed by the hot melt technique from a composition comprising a thermoplastic polymer, a wax, a metal soap, a corrosion inhibitor, a water-insoluble liquid resin, and a solid lubricant.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: April 21, 2020
    Assignees: NIPPON STEEL CORPORATION, VALLOUREC MANNESMANN OIL & GAS FRANCE
    Inventors: Kunio Goto, Takayuki Kamimura, Masaru Takahashi, Keishi Matsumoto, Michihiko Iwamoto, Ryuichi Imai, Stephanie Rai
  • Patent number: 10412908
    Abstract: A hydroponic system (1) is provided with a light-collecting apparatus (3) having a pair of reflecting plates (31a) that are vertically arranged in parallel with a culture surface (23) of a culture panel (21) of a hydroponic unit (2). During a process in which natural light taken from a light-collecting opening (30) propagates while repeatedly reflected by opposing reflecting surfaces of a reflecting plates (31a), by allowing seedlings p that are transplanted into the culture panel (21) to be irradiated with the light through a light-emitting hole (32) bored in the reflecting plate (31a), a culture object can be grown efficiently at a low cost by taking natural light from the outside.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: September 17, 2019
    Assignee: TOYO SEIKAN GROUP HOLDINGS, LTD.
    Inventors: Jun Agari, Katsuhiro Muramoto, Kunio Murai, Takahiro Kamiya, Shinichirou Matsumoto, Kazuto Yoshimura, Akihiko Fujiwara, Shinji Kubo, Mari Nishi, Akane Itoh
  • Patent number: 10377881
    Abstract: The invention provides a composition capable of providing a molded article that has excellent heat resistance and a small weight change against both fluorine plasma exposure and oxygen plasma exposure during a semiconductor manufacturing step. The composition contains a fluorine-containing polymer and a cage silsesquioxane having a specific structure.
    Type: Grant
    Filed: February 17, 2016
    Date of Patent: August 13, 2019
    Assignees: Akita University, DAIKIN INDUSTRIES, LTD.
    Inventors: Kazuya Matsumoto, Mitsutoshi Jikei, Kunio Nishi, Tsuyoshi Noguchi, Fumihiro Kamiya
  • Publication number: 20190177825
    Abstract: Provided is a ferritic stainless steel that has good corrosion resistance and which exhibits good brazeability when subjected to high-temperature brazing with a Ni-containing brazing filler metal. The ferritic stainless steel has a composition containing, in mass %, C: 0.003 to 0.020%, Si: 0.05 to 0.60%, Mn: 0.05 to 0.50%, P: 0.04% or less, S: 0.02% or less, Cr: 17.0 to 24.0%, Ni: 0.20 to 0.80%, Cu: 0.01 to 0.80%, Mo: 0.01 to 2.50%, Al: 0.001 to 0.015%, Nb: 0.25 to 0.60%, and N: 0.020% or less, with the balance being Fe and incidental impurities, the composition satisfying formula (1) below and formula (2) below, Cu+Mo?0.30??(1) 4Ni?(Si+Mn)?0??(2) (wherein Cu and Mo in formula (1) and Ni, Si, and Mn in formula (2) each represent the content (mass %) of the corresponding element).
    Type: Application
    Filed: August 25, 2017
    Publication date: June 13, 2019
    Applicant: JFE Steel Corporation
    Inventors: Takayoshi Yano, Kunio Fukuda, Shin Ishikawa, Katsuhisa Yamauchi, Reiko Sugihara, Hideya Matsumoto
  • Patent number: 9778812
    Abstract: A screen transition diagram creator that creates a screen transition diagram illustrating complicated transition relations in an easy-to-understand manner, including: a screen transition diagram editor providing the screen transition diagram in which transition relations among plural screens are illustrated by plural screen nodes and arrows between the screen nodes; a screen transition pattern applying unit applying a predetermined screen transition pattern to a target screen node group that includes at least part of the screen nodes illustrated in the screen transition diagram to provide a pattern-applied screen node group; and a screen transition structure diagram creator creating a screen transition structure diagram by abridgement processing on the pattern-applied screen node group according to a display layout corresponding to the screen transition pattern.
    Type: Grant
    Filed: October 12, 2012
    Date of Patent: October 3, 2017
    Assignee: Mitsubishi Electric Corporation
    Inventors: Kunio Matsumoto, Koichi Nakagawa
  • Patent number: 9740186
    Abstract: A monitoring control system includes a control device that performs a device control process, and a high-order system that monitors the device control process. The control device includes a control CPU that performs the device control process, and an information CPU that is connected to the control CPU via an internal bus. The control CPU includes a device memory that stores therein device data to be used for the device control process, the device data being related to the device. The information CPU includes a built-in database and a data collection unit. The data collection unit performs a data collection process of reading the device data from the device memory via the internal bus, and storing the read device data in the built-in database.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: August 22, 2017
    Assignee: Mitsubishi Electric Corporation
    Inventors: Koichi Nakagawa, Kunio Matsumoto, Noriyasu Fukatsu, Hiroshi Ashiya
  • Publication number: 20160054718
    Abstract: A monitoring control system includes a control device that performs a device control process, and a high-order system that monitors the device control process. The control device includes a control CPU that performs the device control process, and an information CPU that is connected to the control CPU via an internal bus. The control CPU includes a device memory that stores therein device data to be used for the device control process, the device data being related to the device. The information CPU includes a built-in database and a data collection unit. The data collection unit performs a data collection process of reading the device data from the device memory via the internal bus, and storing the read device data in the built-in database.
    Type: Application
    Filed: January 31, 2014
    Publication date: February 25, 2016
    Applicant: MITSUBISHI ELECTRIC CORPORATION
    Inventors: Koichi NAKAGAWA, Kunio MATSUMOTO, Noriyasu FUKATSU, Hiroshi ASHIYA
  • Publication number: 20150248190
    Abstract: A screen transition diagram creator that creates a screen transition diagram illustrating complicated transition relations in an easy-to-understand manner, including: a screen transition diagram editor providing the screen transition diagram in which transition relations among plural screens are illustrated by plural screen nodes and arrows between the screen nodes; a screen transition pattern applying unit applying a predetermined screen transition pattern to a target screen node group that includes at least part of the screen nodes illustrated in the screen transition diagram to provide a pattern-applied screen node group; and a screen transition structure diagram creator creating a screen transition structure diagram by abridgement processing on the pattern-applied screen node group according to a display layout corresponding to the screen transition pattern.
    Type: Application
    Filed: October 12, 2012
    Publication date: September 3, 2015
    Applicant: Mitsubishi Electric Corporation
    Inventors: Kunio Matsumoto, Koichi Nakagawa
  • Patent number: 8927493
    Abstract: An object of the present invention is to provide a drug for promoting the regeneration of tendon-bone junction tissue or ligament-bone junction tissue.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: January 6, 2015
    Assignee: Kringle Pharma, Inc.
    Inventors: Katsuro Tomita, Hiroyuki Tsuchiya, Katsuhiko Kitaoka, Junsuke Nakase, Keigo Hanada, Kunio Matsumoto
  • Patent number: 8802432
    Abstract: Methods of promoting liver morphogenesis prior to the functioning of blood vessels by culturing liver cells with endothelial cells is provided. Also provided are cell cultures and method of promoting vasculogenesis of liver tissue by contacting liver cells with endothelial cells.
    Type: Grant
    Filed: September 6, 2002
    Date of Patent: August 12, 2014
    Assignee: Fox Chase Cancer Center
    Inventors: Kenneth S. Zaret, Kunio Matsumoto, Hideyuki Yoshitomi
  • Publication number: 20140056910
    Abstract: Provided are a pharmaceutical composition which enhances the sensitivity of a cancer to a molecular target drug, such as gefitinib and erlotinib, wherein the cancer has resistance to the molecular target drug, and a cancer therapeutic agent effective against a cancer having resistance to a molecular target drug, such as gefitinib and erlotinib. The pharmaceutical composition comprising an HGF-MET receptor pathway inhibitor enhances the sensitivity of a cancer to a molecular target drug, such as gefitinib and erlotinib, even though the cancer has resistance to the molecular target drug. The cancer therapeutic agent comprising a molecular target drug in combination with an HGF-MET receptor pathway inhibitor is effective against a cancer having resistance to the molecular target drug.
    Type: Application
    Filed: October 18, 2013
    Publication date: February 27, 2014
    Applicant: Kringle Pharma Inc.
    Inventors: Seiji YANO, Kunio MATSUMOTO
  • Patent number: 8420350
    Abstract: The invention provides a modified glycosylation-deficient HGF and a production method thereof. The glycosylation-deficient HGF is produced by introducing amino acid mutation(s) so that no glycosylation take place at at least one glycosylation site of hepatocyte growth factor.
    Type: Grant
    Filed: March 12, 2010
    Date of Patent: April 16, 2013
    Inventors: Toshikazu Nakamura, Kunio Matsumoto, Kazuhiro Fukuta
  • Patent number: 8383588
    Abstract: A pharmaceutical preparation comprising a hepatocyte growth factor or a DNA molecule encoding the same and the like according to the present invention can suppress the fibrosis of a transplanted organ after organ transplantation. The present invention is useful in the fields of organ transplantation and regeneration therapy.
    Type: Grant
    Filed: November 3, 2011
    Date of Patent: February 26, 2013
    Assignee: Kringle Pharma Inc.
    Inventors: Jun Amano, Ken-ichi Ito, Kazuhiro Yamaura, Kunio Matsumoto, Toshikazu Nakamura
  • Patent number: 8278270
    Abstract: An HGF precursor protein variant, in which a peptide structure comprises a sequence including a peptide chain X inserted between an ? chain of HGF or a polypeptide where 1 to 20 amino-acid residues from the C-terminus of the ? chain are deleted, and a ? chain of HGF or a polypeptide where 1 to 20 amino-acid residues from the N-terminus of the ? chain are deleted; wherein (i) the peptide chain X has an amino-acid sequence of at least two residues, (ii) the peptide chain X can be cleaved by a protease reaction or a chemical reaction, and (iii) a protein obtained by cleaving at least one site of the peptide chain X has HGF action.
    Type: Grant
    Filed: July 1, 2011
    Date of Patent: October 2, 2012
    Assignees: Kringle Pharma Inc., Osaka University
    Inventors: Toshikazu Nakamura, Kunio Matsumoto, Kazuhiro Fukuta, Kiichi Adachi, Daichika Hayata
  • Publication number: 20120149642
    Abstract: A pharmaceutical preparation comprising a hepatocyte growth factor or a DNA molecule encoding the same and the like according to the present invention can suppress the fibrosis of a transplanted organ after organ transplantation. The present invention is useful in the fields of organ transplantation and regeneration therapy.
    Type: Application
    Filed: November 3, 2011
    Publication date: June 14, 2012
    Inventors: Jun AMANO, Ken-ichi Ito, Kazuhiro Yamaura, Kunio Matsumoto, Toshikazu Nakamura
  • Publication number: 20120064090
    Abstract: Provided are a pharmaceutical composition which enhances the sensitivity of a cancer to a molecular target drug, such as gefitinib and erlotinib, wherein the cancer has resistance to the molecular target drug, and a cancer therapeutic agent effective against a cancer having resistance to a molecular target drug, such as gefitinib and erlotinib. The pharmaceutical composition comprising an HGF-MET receptor pathway inhibitor enhances the sensitivity of a cancer to a molecular target drug, such as gefitinib and erlotinib, even though the cancer has resistance to the molecular target drug. The cancer therapeutic agent comprising a molecular target drug in combination with an HGF-MET receptor pathway inhibitor is effective against a cancer having resistance to the molecular target drug.
    Type: Application
    Filed: October 9, 2009
    Publication date: March 15, 2012
    Applicant: KRINGLE PHARMA INC.
    Inventors: Seiji Yano, Kunio Matsumoto
  • Publication number: 20110312887
    Abstract: An object of the present invention is to provide a drug for promoting the regeneration of tendon-bone junction tissue or ligament-bone junction tissue.
    Type: Application
    Filed: October 8, 2009
    Publication date: December 22, 2011
    Applicant: KRINGLE PHARMA, INC.
    Inventors: Katsuro Tomita, Hiroyuki Tsuchiya, Katsuhiko Kitaoka, Junsuke Nakase, Keigo Hanada, Kunio Matsumoto
  • Patent number: 8076289
    Abstract: A pharmaceutical preparation comprising a hepatocyte growth factor or a DNA molecule encoding the same and the like according to the present invention can suppress the fibrosis of a transplanted organ after organ transplantation. The present invention is useful in the fields of organ transplantation and regeneration therapy.
    Type: Grant
    Filed: January 28, 2010
    Date of Patent: December 13, 2011
    Assignee: Kringle Pharma Inc.
    Inventors: Jun Amano, Ken-ichi Ito, Kazuhiro Yamaura, Kunio Matsumoto, Toshikazu Nakamura
  • Publication number: 20110269944
    Abstract: An HGF precursor protein variant, in which a peptide structure comprises a sequence including a peptide chain X inserted between an ? chain of HGF or a polypeptide where 1 to 20 amino-acid residues from the C-terminus of the ? chain are deleted, and a ? chain of HGF or a polypeptide where 1 to 20 amino-acid residues from the N-terminus of the ? chain are deleted; wherein (i) the peptide chain X has an amino-acid sequence of at least two residues, (ii) the peptide chain X can be cleaved by a protease reaction or a chemical reaction, and (iii) a protein obtained by cleaving at least one site of the peptide chain X has HGF action.
    Type: Application
    Filed: July 1, 2011
    Publication date: November 3, 2011
    Inventors: Toshikazu Nakamura, Kunio Matsumoto, Kazuhiro Fukuta, Kiichi Adachi, Daichika Hayata
  • Patent number: 8003607
    Abstract: An HGF precursor protein variant, in which a peptide structure comprises a sequence including a peptide chain X inserted between an ? chain of HGF or a polypeptide where 1 to 20 amino-acid residues from the C-terminus of the ? chain are deleted, and a ? chain of HGF or a polypeptide where 1 to 20 amino-acid residues from the N-terminus of the ? chain are deleted; wherein (i) the peptide chain X has an amino-acid sequence of at least two residues, (ii) the peptide chain X can be cleaved by a protease reaction or a chemical reaction, and (iii) a protein obtained by cleaving at least one site of the peptide chain X has HGF action.
    Type: Grant
    Filed: March 30, 2007
    Date of Patent: August 23, 2011
    Assignees: Kringle Pharma Inc., Osaka University
    Inventors: Toshikazu Nakamura, Kunio Matsumoto, Kazuhiro Fukuta, Kiichi Adachi, Daichika Hayata